• Above all, we make a difference.
  • Complementary and Integrative Therapies References


    1. Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002-2012. National health statistics reports. Number 79. Hyattsville, MD. National Center for Health Statistics, 2015. 
    2. Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD. Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the Nurses' Health Study. Breast Cancer Res Treat. 100(2):219-27, 2006.
    3. Gansler T, Kaw C, Crammer C, Smith T. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer. 113(5):1048-57, 2008.
    4. Saxe GA, Madlensky L, Kealey S, Wu DP, Freeman KL, Pierce JP. Disclosure to physicians of CAM use by breast cancer patients: findings from the Women's Healthy Eating and Living Study. Integr Cancer Ther. 7(3):122-9, 2008.
    5. Davis SR, Lijovic M, Fradkin P, et al. Use of complementary and alternative therapy by women in the first 2 years after diagnosis and treatment of invasive breast cancer. Menopause. 17(5):1004-9, 2010.  
    6. Sohl SJ, Weaver KE, Birdee G, Kent EE, Danhauer SC, Hamilton AS. Characteristics associated with the use of complementary health approaches among long-term cancer survivors. Support Care Cancer. 22(4):927-36, 2014.
    7. National Center for Complementary and Integrative Health. Complementary, alternative, or integrative health: What’s in a name? https://nccih.nih.gov/health/integrative-health, 2016. 
    8. Ang-Lee MK, Moss J and Yuan CS. Herbal medicines and perioperative care. JAMA. 286: 208-216, 2001.
    9. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol. 22(12):2489-503, 2004.
    10. Gerber B, Scholz, Reimer T, Briese V, Janni W. Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat. 95(3):199-209, 2006.
    11. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst. 100(11):773-83, 2008.
    12. Hershman DL1, Unger JM, Crew KD, et al. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol. 31(20):2627-33, 2013.
    13. Ernst E. Complementary and alternative therapies for cancer, in Up-to-Date (Hesketh PJ, Savarese DMF, eds.). Up-to-Date, 2016.

    Updated 12/15/16 

    previous   Complementary and Integrative Therapies Home  


1-877 GO KOMEN